Drug use during pregnancy and breastfeeding should always rely on a favorable risk-benefit balance. Most drugs are prescribed to pregnant or lactating women in off-label use.
In cystic fibrosis patients the potential benefit of treatment most often outbalances the potential risk for the unborn child.